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Summary 
 
 A total of 80 gilts (PIC 327 × 1050; 86 lb 
initial BW) were used in an 84-d study to de-
termine the effect of different nutrients on the 
occurrence of osteochondrosis (OC) lesions, 
several cartilage criteria, growth performance, 
and carcass composition.  Eight dietary treat-
ments were formulated, consisting of 1) con-
trol (standard corn-soy diet, 3.5% choice 
white grease (CWG)) or the control diet plus 
2) fish oil (3.5%) replaced CWG, 3) proline 
and glycine (Pro/Gly; 300 and 200% of ly-
sine), 4) leucine, isoleucine, and valine 
(BCAA; 200, 100, and 100% of lysine, re-
spectively), 5) silicon (1,000 ppm), 6) copper 
and manganese (Cu/Mn; 250 ppm and 100 
ppm, respectively), 7) methionine and 
threonine (Met/Thr; 150 and 100% of lysine), 
and 8) combination of ingredients in diets 2 
through 7.  The diets were formulated slightly 
in excess of the pig’s requirement for lysine 
and to meet minimum true ileal digestibility 
(TID) ratios for the other essential amino ac-
ids.  The diets were also formulated to be iso-
caloric by slightly adjusting the fat (CWG) 
content, and were fed in three phases (1.07, 
0.94, and 0.80% TID Lys).  Upon completion 
of the feeding period, pigs were harvested, and 
the distal aspect of the left femur was evalu-
ated by gross examination for OC lesions.  
The external surface was evaluated for ab-
normalities and given a severity score.  Then 
each femur was sliced into 3-mm sections, and 
lesions were assigned a severity score for the 
underlying articular cartilage, and physeal 
growth plate.  Overall (d 0 to 84), growth per-
formance was unaffected by dietary treatment 
(P>0.21).  Pigs fed diets containing fish oil or 
silicon tended (P<0.07) to have a higher sever-
ity score for external abnormalities (or defects 
in cartilage surface), compared with pigs fed 
the other dietary treatments, with pigs fed the 
control diet, Pro/Gly, or Cu/Mn intermediate.  
Pigs fed high Met/Thr, Cu/Mn, or silicon 
tended (P<0.08) to have lower articular carti-
lage severity scores than scores of pigs fed the 
control diet or BCAA, with the other dietary 
treatments intermediate.  The occurrence of 
OC lesions at the growth plate, total faces with 
lesions, and total number of abnormalities 
were not affected by dietary treatment 
(P>0.23); there was a trend (P<0.14) for pigs 
fed diets containing high Met/Thr or fed the 
combination diet to have lower total severity 
scores than scores of pigs fed the control diet 
or fish oil, with the other treatments interme-
diate.  Pigs fed additional Cu/Mn, Met/Thr, or 
the diet containing all additional ingredients 
had lower overall severity scores (P<0.03) 
than did pigs fed the control diet or fish oil.  
Cartilage compression or shear force were un-
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affected by dietary treatment (P>0.19), but 
pigs fed fish oil had a higher ratio for com-
pression:shear energy (P<0.03), compared 
with the ratio for those fed the control diet, 
Cu/Mn, or silicon; the other treatments were 
intermediate.  In summary, feeding pigs a diet 
containing additional silicon, Cu/Mn, 
Met/Thr, or a combination of these ingredients 
may offer the potential to reduce the incidence 
of osteochondrosis in gilts; more research will 
be required to verify these results. 
 
(Key Words: Cartilage, Finishing Pigs, Osteo-
chondrosis.) 
 
Introduction 
 
 Osteochondrosis (OC) remains a common 
problem among growing swine; it occurs in 
approximately 85 to 90% of all pigs.  Osteo-
chondrosis is an irregularity in the underlying 
growth cartilage that has improperly calcified, 
leaving an area of cartilage protruding into the 
subchondral bone.  It occurs primarily in the 
epiphyseal cartilage of the medial femoral 
condyle, humeral condyle, humeral head, the 
growth plate of the distal ulna, and the costo-
chondral junction.  It can cause reduced re-
productive performance and increased culling 
rates in sows due to lameness, and can de-
crease performance and meat yield of finish-
ing pigs.  The direct cause of OC is relatively 
unknown, but several studies have tried to de-
termine how handling, genetics, or nutrition 
may play a role in its development.  It previ-
ously has been thought that rapid growth rate 
or an abnormality in bone growth that causes 
cartilage canal vessels supplying blood to the 
end of growing long bones to improperly fill 
with bone matrix were the major causes of OC 
in growing pigs.  The reduced blood supply 
results in an area of cartilage that is weakened 
and susceptible to trauma.  When trauma oc-
curs, this underlying weakness can allow 
damage to occur to the articular cartilage sur-
face or prevent the cartilage around it from 
properly maturing and growing at the appro-
priate rate.  This damage to the articular carti-
lage surface results in pain and stiffness asso-
ciated with the common lameness and de-
creased mobility seen in many pigs.   
 
 Therefore, the objective of these experi-
ments was to screen dietary ingredients in-
volved in cartilage and bone metabolism for 
their influence on OC lesion occurrence and 
severity, other cartilage criteria, growth per-
formance, and carcass characteristics in grow-
ing-finishing pigs. 
 
Procedures 
  
 Procedures used in these experiments were 
approved by the Kansas State University 
Animal Care and Use Committee.  A total of 
80 gilts (PIC line 327 × 1050; 86 lb initial 
BW) were blocked by weight in an 84-d 
growth assay.  The experiment was conducted 
at the Kansas State University Swine Research 
and Teaching Center.  Each pen contained one 
pig, for a total of 10 replicates (pigs) per treat-
ment.  The barn contains 80 pens with totally 
slatted concrete flooring (5 × 5 ft), providing 
approximately 25 sq ft/pig.  Each pen was 
equipped with a one-hole dry self-feeder 
(Farmweld, Tuetopolis, IL) and nipple waterer 
to allow ad libitum access to feed and water.    
 
 Gilts were randomly allotted to one of 8 
dietary treatments.  Dietary treatments con-
sisted of 1) control (standard corn-soy diet 
3.5% choice white grease (CWG)) or the con-
trol diet plus 2) fish oil (3.5% replaced CWG), 
3) proline and glycine (Pro/Gly; 300 and 
200% of lysine, respectively), 4) leucine, iso-
leucine, and valine (BCAA; 200, 100, and 
100% of lysine, respectively), 5) silicon 
(1,000 ppm), 6) copper and manganese 
(Cu/Mn; 250 ppm and 100 ppm, respectively), 
7) methionine and threonine (Met/Thr; 150 
and 100% of lysine, respectively), and 8) 
combination of ingredients in diets 2 through 
7 (Tables 1 and 2).  The control diet contained 
amino acidsPro (100% of lysine), Gly (65% of 
lysine), leucine (145% of lysine), isoleucine 
(69% of lysine), valine (76% of lysine), Met 
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(30% of lysine), and Thr (67% of lysine), with 
added amounts of Cu (16.5 and 14 mg/kg in 
Phase 1 and Phase 2 or 3, respectively), Mn 
(40 and 33 mg/kg in Phase 1 and Phase 2 or 3, 
respectively), and Si (0 mg/kg).  Pigs were 
phase-fed over the 84-d period consisting of 
three 28-d phases.  The values used in diet 
formulation and TID digestibilities were based 
on those published in the NRC (1998).  Mini-
mum true ileal digestible (TID) amino acid 
ratios, relative to lysine (Lys), were main-
tained in all diets, with minimum ratios set at 
30% for methionine, 60% for methionine and 
cystine, 65% for threonine, and 16.5% for 
tryptophan.  The Phase 1 diets were formu-
lated to contain 1.07% TID Lys and 1,568 
kcal of metabolizable energy (ME, Table 1), 
the Phase 2 diets contained 0.94% TID Lys 
and 1,573 kcal of ME, and Phase 3 diets con-
tained 0.80% TID Lys and 1,570 kcal of ME.  
In each phase, all essential amino acids other 
than those used in dietary treatments were 
provided at approximately 10% above the re-
quirement for pigs in these weight ranges, and 
added fat concentration differed slightly to 
maintain isocaloric diets.  Other essential nu-
trients were supplied at, or above, NRC esti-
mates.  Diet samples were analyzed for amino 
acid concentration, and contained concentra-
tions similar to formulated amounts.  
 
 Pigs and feeders were weighed every 14 d 
to determine ADG, ADFI, and F/G.  At the 
start of the trial, all gilts were ultrasound 
scanned to determine initial backfat depth and 
to estimate fat-free lean.  At the end of the 
trial, pigs were weighed before transport to the 
Kansas State University Meats Laboratory, 
where the left hind leg was collected for de-
termination of OC lesions, as well as carcass 
data.  Before transport, each pig was marked 
with a distinctive tattoo to allow the carcass 
data to be recorded for each pig.  Carcass data 
were collected on each pig to evaluate 10th rib 
backfat depth, longissimus area, percentage 
lean, fat-free-lean gain, and hot carcass 
weight.  Fat depth was measured with a ruler 
at the 10th rib, 2.3 in off of the midline, 
whereas longissimus muscle area was traced 
on translucent paper and calculated by using a 
grid.  Percentage lean and fat-free-lean index 
were calculated according to NPPC (1994) 
procedures.  
 
 The left femur was collected and removed 
to visually determine the number of cartilage 
abnormalities (indentations or creasing of car-
tilage surface) and the occurrence of OC le-
sions by gross examination of the femoral 
condyle.  The joints were cleaned of excess 
tissue and then stored in 10% formalin until 
evaluation.  After external evaluation, the dis-
tal end of the femur was sliced into 3-mm sec-
tions by cutting perpendicular to the long axis 
of the bone with a bandsaw.  This resulted in 
12 faces (cut surfaces) for evaluation of le-
sions.  Each joint was evaluated for the num-
ber of external abnormalities, OC lesions at 
the articular cartilage, and growth plate carti-
lage, and lesions were given a severity score 
(0 to 4) for all three locations, where 0 = nor-
mal, 1 = mild, 2 = moderate, 3 = severe, and  
4 = OC dissecans, based on the extent of tis-
sue involvement.  Each joint was also catego-
rized as “Yes” or “No” for the presence or ab-
sence of osteochondrosis lesions.   
 
 In addition, a cartilage sample was cut 
from the patella for cartilage property analy-
sis.  Cartilage samples were weighed, meas-
ured for thickness and length with a caliper, 
and then tested for the ability to absorb com-
pression or to resist shearing by using an In-
stron machine (Model 4201 was used to de-
termine cartilage properties).  Each cartilage 
sample was placed between two flat surfaces 
of the Instron to perform texture profile analy-
sis and compressed half of its thickness to 
measure the ability of the cartilage to resist 
compression force.  A second measure was 
conducted in which the cartilage was cut by 
using a Warner-Bratzler shear blade, to deter-
mine the ability of the cartilage to withstand 
shearing force.  Compression values and shear 
values were adjusted to cartilage weight/g to 
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equalize for differences in the actual cartilage 
weight.   
 
 Data were analyzed as a randomized com-
plete-block design by using the PROC 
MIXED procedure of SAS, with pig as the 
experimental unit.  The response criteria of 
growth performance, carcass composition, 
cartilage compression and shearing, and num-
ber of abnormalities were tested.  Although 
scored categorically, severity of abnormalities 
scores for the external surface, articular carti-
lage, and growth plate cartilage were done via 
PROC MIXED because the small number of 
observations at some of the severity scores 
prevented categorical analysis.  An overall 
score using the number of abnormalities at 
each location, multiplied by the severity at 
each location and then summed, was created 
to provide an overall severity score or indica-
tion of joint status.  A ‘Yes’ or ‘No’ rating of 
the presence of OC lesions was compared by 
using the Cochran-Mantzel-Haenszel test sta-
tistic for row mean scores in PROC FREQ.  
To evaluate the effect of amino acids or added 
minerals, relative to the other dietary treat-
ments, single-degree-of-freedom contrasts 
were constructed. 
 
Results and Discussion 
 
 Overall (d 0 to 84), growth performance 
was unaffected by dietary treatment (P>0.21, 
Table 3), but pigs fed high Met/Thr tended 
(P<0.10) to have increased longissimus mus-
cle area, compared with pigs in the other die-
tary treatments, whereas pigs fed fish oil were 
intermediate; no other carcass differences 
were observed (P>0.84).  This response is 
similar to previous trials in which excess me-
thionine has increased lean muscle deposition. 
 
 For the joint evaluation data, the number 
of animals with OC was not affected by die-
tary treatment (P>0.52).  Pigs fed diets con-
taining fish oil or silicon tended (P<0.07, Ta-
ble 5) to have a higher severity score for ex-
ternal abnormalities, compared with pigs in 
the other dietary treatments; scores of pigs fed 
the control diet, Pro/Gly, or Cu/Mn were in-
termediate, but the prevalence of external ab-
normalities and severity scores were not dif-
ferent from controls.  Pigs fed high Met/Thr, 
Cu/Mn, or silicon tended (P<0.08) to have 
lower articular cartilage lesion severity scores 
than those of pigs fed the control diet or 
BCAA, with the other dietary treatments in-
termediate.  The distribution of severity scores 
are shown for the three treatments that tended 
to reduce articular cartilage lesion severity, 
compared with the control (Chart 1).  The oc-
currence of OC lesions at the growth plate, 
total faces with lesions, or total number of ab-
normalities were not affected by dietary 
treatment (P>0.23); there was a numerical 
trend (P<0.14) for pigs fed diets containing 
high Met/Thr or the combination diet contain-
ing all ingredients to have lower total severity 
scores than those of pigs fed the control diet or 
fish oil, with the other treatments intermedi-
ate.  Finally, pigs fed additional Cu/Mn, 
Met/Thr, or the diet containing all additional 
ingredients, had lower overall severity scores 
(P<0.03), compared with scores of pigs fed 
the control diet or fish oil.  An intermediate 
response to additional Pro/Gly and silicon was 
also observed, compared with the control diet 
or fish oil.  Pigs fed the diets containing addi-
tional amino acids had lower external and total 
severity scores (P<0.05) than did pigs fed the 
other dietary treatments, but pigs fed diets 
containing minerals (silicon or copper and 
manganese) tended (P<0.08) to have lower 
articular cartilage severity scores and had 
lower overall severity scores (P<0.02). 
 
 Cartilage compression or shear force were 
unaffected by dietary treatment (P>0.19, Ta-
ble 6), but pigs fed fish oil had a higher ratio 
for compression:shear energy (P<0.03), com-
pared with those fed the control diet, Cu/Mn, 
or silicon; the other treatments were interme-
diate.  This suggests that fish oil stiffened the 
cartilage or has less ability to absorb impact 
force and less ability to resist shear forces.  
This may have been due to the ability of n-3 
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fatty acids to inhibit matrix metalloproteinases 
that degrade collagen.  In doing so, the normal 
turnover of cartilage may have been inhibited, 
resulting in collagen with decreased ability to 
function in absorbing energy or resist breaking 
apart. 
 
 In summary, feeding pigs high Met/Thr 
not only increased loin eye area, but tended to 
reduce the total severity score, compared with 
the control diet.  In addition, feeding pigs diets 
containing high Met/Thr, silicon, or Cu/Mn 
may reduce the severity of OC lesions at the 
articular cartilage (Chart 1).  Although there is 
no requirement established for silicon in pigs, 
it may be essential for proper bone and carti-
lage strength due to its role in chondroitin sul-
fate metabolism and collagen formation.  
Copper also is required for the enzyme lysyl 
oxidase that helps form crosslinks in cartilage 
 
between collagen molecules, and may help 
stabilize the cartilage matrix from degradation 
or provide vascular stability to blood vessel 
walls.  Finally, Met/Thr have indirect effects 
on cartilage metabolism.  Methionine is 
thought to drive cartilage synthesis and also 
donate sulfur for the process of proteoglycan 
formation.  Threonine can be converted to 
glycine, which is part of the collagen, and is 
also incorporated into collagen in small quan-
tities itself.  Feeding ingredients such as 
Met/Thr, Cu/Mn, silicon, or a combination of 
these ingredients that are involved in cartilage 
and bone metabolism may help reduce the in-
cidence of OC by either positively influencing 
cartilage/bone metabolism or by preventing 
excess cartilage degradation, but this evidence 
only provides initial information and more 
research will be required to verify the results 
found in this study. 
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Table 1.  Diet Composition (As-fed Basis)ab
Item Phase 1 Phase 2 Phase 3 
Ingredient    
   Corn 62.65 68.60 74.05 
   Soybean meal (46.5% CP) 30.45 24.95 19.50 
   Choice white greasec 3.50 3.50 3.50 
   Monocalcium phosphate (21 % P) 1.50 1.25 1.25 
   Limestone 1.05 1.00 1.00 
   Salt 0.35 0.35 0.35 
   Vitamin premix 0.15 0.13 0.13 
   Trace mineral premix 0.15 0.13 0.13 
   L-lysine HCl 0.15 0.15 0.15 
   DL-methionine 0.06 0.03 - 
   L-threonine 0.06 0.05 0.05 
Total 100.00 100.00 100.00 
    
Calculated Analysis       
   Total lysine, % 1.20 1.05 0.90 
   True ileal digestible amino acids    
      Lysine, % 1.07 0.94 0.80 
      Isoleucine:lysine ratio, % 69 69 70 
      Leucine:lysine ratio, % 145 154 164 
      Methionine:lysine ratio, % 32 31 29 
      Met & Cys:lysine ratio, % 60 60 60 
      Threonine:lysine ratio, % 65 66 68 
      Tryptophan:lysine ratio, % 20 19 19 
      Valine:lysine ratio, % 76 78 80 
   ME, kcal/lb 1568 1573 1570 
   CP, % 19.5 17.4 15.4 
   Ca, % 0.80 0.72 0.72 
   P, % 0.70 0.62 0.62 
   Lysine:calorie ratio, g/mcal 3.47 3.03 2.60 
aDiets fed in meal form in three 28-d phases. 
bDietary treatments were created by substituting ingredients for corn, except that fish oil re-
placed CWG. 
cAmount of CWG varied slightly in the diet so that diets were isocaloric in each phase. 
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Table 2.  Dietary Treatmentsa
Treatment 
Controlb Standard corn-soybean meal diet with 3.5% choice white grease. 
Fish oil 3.5% fish oil replaced choice white grease, resulting in a n-6 to n-3 ratio of 
2:1. 
Pro/Gly 
 
L-proline at 2.55% and L-glycine at 1.70% were added to create a ratio of 
proline:lysine of 300% and a glycine:lysine ratio of 200%.  
BCAA 
 
L-leucine was added at 0.60%, L-isoleucine at 0.35%, and L-valine at 0.29% 
to create a leucine:lysine ratio of 200%, isoleucine:lysine ratio of 100%, and 
valine:lysine ratio of 100%. 
Silicon Silicon was added at 0.80% (Zeolite A) to create the silicon diet (1,000 ppm).
Cu/Mn Copper was added at 0.1% (250 ppm) and manganese was added at 0.02% 
(100 ppm). 
Met/Thr 
 
DL-methionine was added at 1.05% to create a methionine:lysine ratio of 
150% and L-threonine was added at 0.45% to create a threonine:lysine ratio 
of 100%. 
All ingredients Contained all additional dietary ingredients at the expense of corn and choice 
white grease. 
aAll dietary treatments were fed in meal form and maintained throughout the three 28-d feeding 
phases. 
bThe control diet contained amino acid levels of Pro (100% of lysine), Gly (65% of lysine), leu-
cine (145% of lysine), isoleucine (69% of lysine), valine (76% of lysine), Met (30% of lysine), 
and Thr (67% of lysine), with mineral levels of Cu (16.5 and 14 mg/kg in Phase 1 and Phase 2 
or 3, respectively), Mn (40 and 33 mg/kg in Phase 1 and Phase 2 or 3, respectively), and Si (0 
mg/kg). 
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Table 3.  Effect of Different Nutrients on Growth Performance and Carcass Compositiona
   Treatment  Probability, P <
Item Control Fish Oil Pro/Gly BCAA Silicon Cu/Mn Met/Thr
All  
Ingredientsb SED Treatment 
Growth, d 0 to 84c           
   ADG, lb 2.40 2.34 2.37 2.48 2.44 2.48 2.28 2.28 0.104 0.21 
   ADFI, lb 6.13 5.85 5.97 6.17 6.16 6.04 5.82 5.68 0.248 0.26 
   Feed/Gain 2.56 2.50 2.52 2.50 2.53 2.45 2.55 2.50 0.087 0.91 
Carcass d  ata           
   Initial backfat, in 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.02 0.83 
   HCW, lbd 209.6 205.8 205.0 209.1 212.7 206.8 201.3 197.1 - 0.43 
   Final backfat, in 0.63 0.62 0.59 0.56 0.56 0.61 0.63 0.63 0.06 0.84 
   Final LEA, in 7.55f 7.92fg 7.46f 7.52f 7.49f 7.58f 8.27g 7.28f 0.327 0.10 
   Fat-free lean index  55.4 55.7 55.3 55.7 55.8 55.5 56.1 54.5 1.09 0.90 
   Fat-free lean gain, lbs/daye 0.936 0.953 0.949 0.955 0.957 0.948 0.960 0.926 0.025 0.88 
aEach value is the mean of 9 or 10 replications, with pigs initially 86 lbs, and average final weight of 290 lbs. 
bDiet contained all treatment ingredients combined into one diet. 
cPigs were fed diets in meal form in three 28-d phases. 
dHot carcass weight was used as a covariate in analysis, except for fat-free-lean gain. 
eCalculated as the final fat-free lean minus initial fat-free lean, divided by days on feed. 
f,gTreatments with different superscripts differ P<0.05. 
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Table 4.  Effect of Different Nutrients on Cartilage Parametersa  
  Treatment  Probability, P <
  Control Fish Oil Pro/Gly BCAA Silicon Cu/Mn Met/Thr Allb SED Treatment 
Cartilage measures           
   Cartilage weight, gc 1.07 1.26 1.08 1.22 1.24 1.10 1.16 1.26 0.138 0.65 
   Cartilage thickness, cmd 0.38 0.37 0.36 0.38 0.36 0.33 0.36 0.39 0.042 0.96 
   Cartilage length, cme 3.19 3.37 3.22 3.25 3.28 3.21 3.30 3.32 0.109 0.71 
Instron measures           
   Compression energy, n/gf 85.4 126.9 144.7 102.5 86.0 59.8 116.4 110.7 39.22 0.59 
   Shear energy, n/gg 516.9 378.7 437.9 505.2 523.1 565.8 505.4 561.6 74.03 0.19 
   Total energy, n/g2h 1271.4 1226.8 976.5 1303.3 1342.3 1401.9 1326.9 1539.6 291.54 0.73 
   Ratio of CE/SEi 0.15k 0.41j 0.31jk 0.25jk 0.17k 0.15k 0.25jk 0.21 0.081 0.03 
aEach value is the mean of 9 or 10 replications, with pigs initially 86 lb, and a final weight of 290 lbs. 
bDiet contained all dietary ingredients added into one diet 
cWeight of the cartilage sample taken from the patella.  
dThe thickness of the cartilage sample. 
eThe length of the cartilage sample. 
fAmount of energy in newtons per gram of cartilage to compress the cartilage half its thickness. 
gAmount of initial energy in newtons per gram of cartilage to shear the cartilage into two pieces. 
hThe total amount of energy required to shear the cartilage into two pieces. 
iThe ratio of compression force or energy to shear force or energy, in which smaller values would indicate more desirable characteristics. 
j,kTreatments with different superscripts differ by P<0.05. 
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Table 5. Effect of Different Nutrients on the Occurrence of Osteochondrosisa  
          Probability, P < 
 Treatment   Contrasts 
   Fish Pro/   Cu/ Meth/    Minerals Minerals AAs 
Item Control Oil Gly BCAA Silicon Mn Thr Allb SED Treatment vs AAs vs others vs others
Total animals/trtc 10 10 10 10 10 9 10 10 - - - - - 
Animals with lesionsd 9 9 9 9 6 7 7 7 1.5 0.52 - - - 
Exter  nal              
   Abnormalitiese 1.9op 2.6o 2.0op 1.4p 2.5o 1.8op 1.3p 1.4p 0.56 0.13 0.31 0.86 0.02 
   Severity scoref 2.1op 2.5o 1.9op 1.4p 2.4o 1.8op 1.3p 1.4p 0.48 0.07 0.24 0.94 0.01 
Articular cartilage              
   Number of facesg 5.0o 4.5op 2.4op 5.0o 2.2q 2.3op 2.6op 4.1op 1.44 0.16 0.57 0.19 0.87 
   Severity scoreh 2.0o 1.3opq 1.2opq 1.6op 0.7q 0.8pq 0.7q 1.3opq 0.48 0.08 0.38 0.08 0.98 
Growth plate              
   Number of facesi 0.9 1.7 1.2 0.6 1.2 1.6 1.8 0.2 0.68 0.23 0.58 0.47 0.25 
   Severity scorej 0.6 1.1 0.9 0.6 0.8 0.8 1.0 0.1 0.43 0.38 0.27 0.21 0.43 
Ove  rall              
   Total facesk  5.9 6.2 3.6 5.6 3.4 3.9 4.4 4.3 1.81 0.63 0.52 0.17 0.68 
   Total abnormalitiesl 8.7 8.8 5.6 7.0 5.9 5.7 5.7 5.7 1.89 0.54 0.75 0.21 0.27 
   Total severitym 4.7o 4.9o 4.0op 3.6op 3.9op 3.3op 3.0p 2.8p 0.85 0.14 0.70 0.12 0.05 
   Overall scoren 17.1o 15.0op 8.8pq 12.4opq 8.4pq 6.4q 6.6q 7.0q 3.76 0.03 0.36 0.02 0.11 
   Final weight 294.6 282.3 291.4 293.4 298.8 287.3 284.2 285.4 10.23 0.70 0.89 0.81 0.68 
aEach value is the mean of 9 or 10 replications, with one pig per pen, initially 86 lb.  bDiet contained all dietary ingredients added into one diet.  cTotal ani-
mals evaluated per treatment.  dThe number of animals with OCD lesions (Cochran-Mantzel-Haenszel test).  eNumber of abnormalities noted upon visual 
evaluation of the intact joint.  fSeverity score (0-4 with 0 normal, 1 mild, 2 moderate, 3 severe, and 4 OC dissecans) of abnormalities by visual evaluation of 
the external joint.  gThe number of faces showing lesions from cutting the condyle into 3mm slices per animal.  hSeverity score (0-4 with 0 normal, 1 mild, 2 
moderate, 3 severe, and 4 OC dissecans) for the articular cartilage faces.  iThe number of faces showing lesions in the growth plate per animal.  jSeverity 
score (0-4 with 0 normal, 1 mild, 2 moderate, 3 severe, and 4 OC dissecans) for the faces in the growth plate.  kTotal faces showing lesions at the articular 
cartilage and growth plate, evaluating 12 cut surfaces.  lSum of external abnormalities, articular faces, and growth plate faces.  mSum of severity scores for 
external abnormalities, articular cartilage, and growth plate faces.  nCalculated as the number of abnormalities multiplied by the severity for each location, 
and then summed.  o,p,qTreatments with different superscripts differ (P<0.05). 
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Chart 1.  Distribution of Articular Cartilage Severity Scores for Treatments Silicon, 
Cu/Mn, and Methionine/threonine, Compared with Controls.  A = control, E = silicon, F = 
Cu/Mn, and G = methionine/threonine (Only nine pigs fed Cu/Mn finished the experiment.)  
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